Pulling SEC filings + quote and writing the call…

Strategic Education, Inc.
Next earnings Jul 28, 2026 · consensus $1.84 EPS, $334M rev
Last earnings -13.7% on 2026-04-23
Debt-free, cash-generative for-profit educator at 14x earnings with double-digit EPS growth and a buyback engine — cheap for the quality.
P/E (price / FY diluted EPS) 14.3 · FY2025
Quality fundamentals and an attractive price line up (~25% below fair value) — the rarer case where both the business and the entry look good.
STRA is a high-quality, capital-light education company trading like a no-growth value stock. At $77.10 the shares fetch 14.3x FY2025 diluted EPS of $5.41 and just 1.4x sales — undemanding for a business that grew net income +12.4%, operating income +12.0% and EPS +15.8% last year. The balance sheet is pristine: $1.65B equity against only $392M total liabilities (0.24x), no long-term debt and $141M cash. Cash generation is the real story — operating cash flow rose 17% to $198M against $44.3M of capex, leaving roughly $154M of free cash (an ~8.8% FCF yield) that management is aggressively returning: $139M of buybacks (shares -7.2% YoY) plus $57.5M of dividends. The buyback is doing heavy lifting on per-share growth and, at this multiple, is accretive.
The filing tempers the enthusiasm on organic momentum. USHE average enrollment fell 1.4% to 86,285, and trailing-4Q Title IV (federal aid) per credit earned is declining steeply — down 9.6% as of Q3 2025 and worsening sequentially through the year. The bull reframe is in the same disclosure: that Title IV decline reflects a deliberate mix shift toward employer-funded students (ETS affiliation rose to 32.3% of enrollment from 29.6%) and lower-cost Sophia Learning pathways, which structurally lowers regulatory dependence on federal aid. Critically, student persistence improved to 88.3% from 86.9%, a leading indicator of retained revenue, and total revenue still grew 4.0% to $1.27B with three diversified segments (USHE, ETS, and Australia's Torrens/ANZ).
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 1:11 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Is STRA a buy? The one-page verdict, explained →
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.13B | $1.07B | $1.13B | $1.22B | $1.27B |
| Gross profit | — | — | — | — | — |
| Operating income | $73.9M | $70.8M | $95.3M | $156M | $174M |
| Net income | $55.1M | $46.7M | $69.8M | $113M | $127M |
| Diluted EPS | $2.28 | $1.94 | $2.91 | $4.67 | $5.41 |
| Net margin | 4.9% | 4.4% | 6.2% | 9.2% | 10.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Q1 FY26 10-Q; continued profit/EPS growth, 7% fewer shares YoY
Q1 FY26 10-Q; continued profit/EPS growth, 7% fewer shares YoY
Annual proxy: board, exec pay, routine shareholder votes
FY25 10-K: rev $1.27B +4%, EPS $5.41 +16%; but USHE enrollment -1.4%, Title IV -9.6%
Q4/FY25 results: net income +12%, EPS +16%, buybacks ramped to $139M
Q3 FY25 10-Q; rising persistence, employer-affiliated mix growing
Q3 FY25 10-Q; rising persistence, employer-affiliated mix growing
Q2 FY25 10-Q; profit and cash flow growth continue
Q2 FY25 10-Q; profit and cash flow growth continue
Sources: SEC EDGAR (CIK 0001013934, latest 10-Q filed 2026-04-23) · EODHD · Proprietary analysis · as of 6/30/2026, 5:11:45 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 1 open-market buy · 2 sales
| 2026-06-04 | Hokenson Christa CHIEF HUMAN RESOURCES OFFICER | Sell | 2.00K @ $80.00 | $160K |
| 2026-05-05 | WAITE G THOMAS III Director | Sell | 666.00 @ $77.68 | $51.7K |
| 2026-04-24 | Thawley Michael Director | Buy | 665.00 @ $72.71 | $48.4K |
| 2026-04-22 | Thawley Michael Director | Award | 1.44K | |
| 2026-04-22 | Slocum William J Director | Award | 1.44K | |
| 2026-04-22 | WAITE G THOMAS III Director | Award | 1.44K | |
| 2026-04-22 | Sasse Benjamin E Director | Award | 1.44K | |
| 2026-04-22 | Sasse Benjamin E Director | Award | 957.00 @ $83.62 | $80.0K |
| 2026-04-22 | McRobbie Michael A. Director | Award | 1.44K | |
| 2026-04-22 | GRUSKY ROBERT R Director | Award | 1.44K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.